Clinical Trial Update: Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial update for masitinib in primary progressive or non-active secondary progressive multiple sclerosis, currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Masitinib (masitinib)

Snippet

Sponsor: AB Science | Conditions: Progressive Multiple Sclerosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING